Shingrix

Pic:getty/andrewpopov

GSK ups sales guidance on back of Shingrix strength

By Ben Hargreaves

GSK’s first quarter following the demerger of its consumer health business sees the company raise its 2022 sales guidance to between 6-8%, up from 5-7% on its previous estimation.